المؤلفون: Gholami L; Nanotechnology Research Center, Institute of Pharmaceutical Technology, Mashhad University of Medical Sciences, Mashhad, Iran., Ivari JR; Department of Medical Biotechnology and Nanotechnology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Nasab NK; Department of Medical Biotechnology and Nanotechnology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Oskuee RK; Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran., Sathyapalan T; Academic Diabetes, Endocrinology and Metabolism, Hull York Medical School, University of Hull, United Kingdom of Great Britain and Northern Ireland., Sahebkar A; Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.; Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran.; School of Medicine, The University of Western Australia, Perth, Australia.; School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.

المصدر: Current medicinal chemistry [Curr Med Chem] 2023; Vol. 30 (3), pp. 335-355.

نوع المنشور: Review; Journal Article

بيانات الدورية: Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 9440157 Publication Model: Print Cited Medium: Internet ISSN: 1875-533X (Electronic) Linking ISSN: 09298673 NLM ISO Abbreviation: Curr Med Chem Subsets: MEDLINE

مواضيع طبية MeSH: Dendrimers*/therapeutic use , Lung Neoplasms*/drug therapy, Female ; Humans ; Male ; Liposomes ; Quality of Life ; Developed Countries